2023 Q3 Form 10-Q Financial Statement

#000107997323000950 Filed on July 13, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2
Revenue $14.62M $18.95M
YoY Change -2.54% -9.45%
Cost Of Revenue $11.57M $14.53M
YoY Change -7.07% -6.66%
Gross Profit $3.050M $4.413M
YoY Change 19.55% -17.55%
Gross Profit Margin 20.86% 23.29%
Selling, General & Admin $2.560M $3.062M
YoY Change -6.85% 172.05%
% of Gross Profit 83.93% 69.39%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $100.0K $99.96K
YoY Change 21.04% 20.01%
% of Gross Profit 3.28% 2.26%
Operating Expenses $2.660M $3.162M
YoY Change -6.03% -5.12%
Operating Profit $390.0K $1.251M
YoY Change -239.46% -38.06%
Interest Expense -$100.0K -$152.9K
YoY Change 55.81% -418.75%
% of Operating Profit -25.64% -12.22%
Other Income/Expense, Net $0.00 $0.00
YoY Change -100.0% -100.0%
Pretax Income $360.0K $1.098M
YoY Change -230.79% -44.33%
Income Tax $70.00K $363.2K
% Of Pretax Income 19.44% 33.07%
Net Earnings $290.0K $735.0K
YoY Change -238.98% -50.81%
Net Earnings / Revenue 1.98% 3.88%
Basic Earnings Per Share $0.21
Diluted Earnings Per Share $0.08 $0.21
COMMON SHARES
Basic Shares Outstanding 3.499M shares 3.499M shares
Diluted Shares Outstanding 3.499M shares

Balance Sheet

Concept 2023 Q3 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $80.00K $2.716M
YoY Change -83.49% 27.49%
Cash & Equivalents $83.70K $2.716M
Short-Term Investments
Other Short-Term Assets $630.0K $870.2K
YoY Change -52.33% -61.52%
Inventory $18.34M $20.53M
Prepaid Expenses $630.8K $870.1K
Receivables $5.635M $7.530M
Other Receivables $0.00 $0.00
Total Short-Term Assets $24.69M $31.65M
YoY Change -16.68% -2.82%
LONG-TERM ASSETS
Property, Plant & Equipment $4.655M $4.746M
YoY Change -3.58% 1.81%
Goodwill
YoY Change
Intangibles $134.8K $134.4K
YoY Change 304.24% 346.63%
Long-Term Investments
YoY Change
Other Assets $320.0K $391.6K
YoY Change 1180.0%
Total Long-Term Assets $5.110M $5.272M
YoY Change 4.57% 12.37%
TOTAL ASSETS
Total Short-Term Assets $24.69M $31.65M
Total Long-Term Assets $5.110M $5.272M
Total Assets $29.80M $36.92M
YoY Change -13.67% -0.9%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.181M $2.631M
YoY Change 39.28% 46.6%
Accrued Expenses $2.113M $2.332M
YoY Change 13.86% 14.03%
Deferred Revenue
YoY Change
Short-Term Debt $1.260M $8.000M
YoY Change -82.0% -11.11%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $5.700M $13.11M
YoY Change -45.31% 2.11%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $5.700M $13.11M
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $5.701M $13.11M
YoY Change -45.3% 1.09%
SHAREHOLDERS EQUITY
Retained Earnings $22.51M $22.22M
YoY Change -0.09% -2.28%
Common Stock $825.5K $825.5K
YoY Change 0.1% 0.17%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $24.10M $23.81M
YoY Change
Total Liabilities & Shareholders Equity $29.80M $36.92M
YoY Change -13.67% -0.9%

Cashflow Statement

Concept 2023 Q3 2023 Q2
OPERATING ACTIVITIES
Net Income $290.0K $735.0K
YoY Change -238.98% -50.81%
Depreciation, Depletion And Amortization $100.0K $99.96K
YoY Change 21.04% 20.01%
Cash From Operating Activities $4.050M $2.964M
YoY Change 572.67% 61.59%
INVESTING ACTIVITIES
Capital Expenditures $0.00 -$85.99K
YoY Change -100.0% -16.48%
Acquisitions
YoY Change
Other Investing Activities $70.00K -$102.5K
YoY Change -2077.4%
Cash From Investing Activities $60.00K -$16.51K
YoY Change -124.19% -83.96%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -6.740M -500.0K
YoY Change 237.0% 0.0%
NET CHANGE
Cash From Operating Activities 4.050M 2.964M
Cash From Investing Activities 60.00K -16.51K
Cash From Financing Activities -6.740M -500.0K
Net Change In Cash -2.630M 2.448M
YoY Change 59.78% 98.77%
FREE CASH FLOW
Cash From Operating Activities $4.050M $2.964M
Capital Expenditures $0.00 -$85.99K
Free Cash Flow $4.050M $3.050M
YoY Change 378.38% 57.44%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0000885307
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--08-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
CY2023Q2 jctcf Prepaid Income Taxes
PrepaidIncomeTaxes
usd
CY2022Q3 us-gaap Taxes Payable Current
TaxesPayableCurrent
usd
us-gaap Other Income
OtherIncome
usd
us-gaap Increase Decrease In Accrued Taxes Payable
IncreaseDecreaseInAccruedTaxesPayable
usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
usd
CY2023Q2 us-gaap Incremental Common Shares Attributable To Written Put Options
IncrementalCommonSharesAttributableToWrittenPutOptions
shares
CY2022Q2 us-gaap Incremental Common Shares Attributable To Written Put Options
IncrementalCommonSharesAttributableToWrittenPutOptions
shares
us-gaap Incremental Common Shares Attributable To Written Put Options
IncrementalCommonSharesAttributableToWrittenPutOptions
shares
us-gaap Incremental Common Shares Attributable To Written Put Options
IncrementalCommonSharesAttributableToWrittenPutOptions
shares
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-05-31
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-19954
dei Entity Registrant Name
EntityRegistrantName
JEWETT-CAMERON TRADING COMPANY LTD
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
A1
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
00-0000000
dei Entity Address Address Line1
EntityAddressAddressLine1
32275 N.W. Hillcrest
dei Entity Address City Or Town
EntityAddressCityOrTown
North Plains
dei Entity Address State Or Province
EntityAddressStateOrProvince
OR
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
97133
dei City Area Code
CityAreaCode
(503)
dei Local Phone Number
LocalPhoneNumber
647-0110
dei Security12b Title
Security12bTitle
Common Stock, no par value
dei Trading Symbol
TradingSymbol
JCTCF
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
3498899 shares
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2716051 usd
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
484463 usd
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0 usd
CY2022Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0 usd
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
7530135 usd
CY2022Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
7191646 usd
CY2023Q2 us-gaap Inventory Net Of Allowances Customer Advances And Progress Billings
InventoryNetOfAllowancesCustomerAdvancesAndProgressBillings
449707 usd
CY2022Q3 us-gaap Inventory Net Of Allowances Customer Advances And Progress Billings
InventoryNetOfAllowancesCustomerAdvancesAndProgressBillings
800000 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
20529230 usd
CY2022Q3 us-gaap Inventory Net
InventoryNet
20632313 usd
CY2023Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
870148 usd
CY2022Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1112575 usd
CY2022Q3 jctcf Prepaid Income Taxes
PrepaidIncomeTaxes
208963 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
31645564 usd
CY2022Q3 us-gaap Assets Current
AssetsCurrent
29629960 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4745987 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4828420 usd
CY2023Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
134399 usd
CY2022Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
33358 usd
CY2023Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
391564 usd
CY2022Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
24998 usd
CY2023Q2 us-gaap Assets
Assets
36917514 usd
CY2022Q3 us-gaap Assets
Assets
34516736 usd
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
2631045 usd
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
1566047 usd
CY2023Q2 us-gaap Notes Payable
NotesPayable
8000000 usd
CY2022Q3 us-gaap Notes Payable
NotesPayable
7000000 usd
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2332148 usd
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1856039 usd
CY2023Q2 us-gaap Taxes Payable Current
TaxesPayableCurrent
147215 usd
CY2023Q2 us-gaap Liabilities
Liabilities
13110408 usd
CY2022Q3 us-gaap Liabilities
Liabilities
10422086 usd
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
21567564 shares
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
21567564 shares
CY2023Q2 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2022Q3 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q2 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
0
CY2022Q3 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
0
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3498899 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3495342 shares
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
825468 usd
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
824629 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
765055 usd
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
742591 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
22216583 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
22527430 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
23807106 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
24094650 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
36917514 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
34516736 usd
CY2023Q2 us-gaap Revenues
Revenues
18945738 usd
CY2022Q2 us-gaap Revenues
Revenues
20922190 usd
us-gaap Revenues
Revenues
39666658 usd
us-gaap Revenues
Revenues
47900665 usd
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
14532366 usd
CY2022Q2 us-gaap Cost Of Revenue
CostOfRevenue
15569380 usd
us-gaap Cost Of Revenue
CostOfRevenue
30473044 usd
us-gaap Cost Of Revenue
CostOfRevenue
36658766 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
4413372 usd
CY2022Q2 us-gaap Gross Profit
GrossProfit
5352810 usd
us-gaap Gross Profit
GrossProfit
9193614 usd
us-gaap Gross Profit
GrossProfit
11241899 usd
CY2023Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
961566 usd
CY2022Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1125692 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2884463 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2798094 usd
CY2023Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
99962 usd
CY2022Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
83291 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
299577 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
237001 usd
CY2023Q2 us-gaap Salaries And Wages
SalariesAndWages
2100825 usd
CY2022Q2 us-gaap Salaries And Wages
SalariesAndWages
2124183 usd
us-gaap Salaries And Wages
SalariesAndWages
5975438 usd
us-gaap Salaries And Wages
SalariesAndWages
5957601 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
3162353 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
3333166 usd
us-gaap Operating Expenses
OperatingExpenses
9159478 usd
us-gaap Operating Expenses
OperatingExpenses
8992696 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
1251019 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
2019644 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
34136 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
2249203 usd
CY2022Q2 us-gaap Other Income
OtherIncome
903 usd
us-gaap Other Income
OtherIncome
-294097 usd
CY2023Q2 us-gaap Interest Expense
InterestExpense
152905 usd
CY2022Q2 us-gaap Interest Expense
InterestExpense
47972 usd
us-gaap Interest Expense
InterestExpense
353987 usd
us-gaap Interest Expense
InterestExpense
98868 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-152905 usd
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-47069 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-353987 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-392965 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
1098114 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
1972575 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-319851 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
1856238 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
363163 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
478464 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-9004 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
483449 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
734951 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
1494111 usd
us-gaap Net Income Loss
NetIncomeLoss
-310847 usd
us-gaap Net Income Loss
NetIncomeLoss
1372789 usd
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.21
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.43
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.09
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.39
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.21
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.43
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.09
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.39
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3498899 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3492842 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3498000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3492266 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3498899 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3492842 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3498000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3492266 shares
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
22873689 usd
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
39386 usd
us-gaap Profit Loss
ProfitLoss
1372789 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
24285864 usd
CY2022Q3 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
17452 usd
CY2022Q3 us-gaap Profit Loss
ProfitLoss
-208666 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
24094650 usd
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
23303 usd
us-gaap Profit Loss
ProfitLoss
-310847 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
23807106 usd
us-gaap Net Income Loss
NetIncomeLoss
-310847 usd
us-gaap Net Income Loss
NetIncomeLoss
1372789 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
299577 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
237001 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-23303 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-39386 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-366566 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
11552 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
338489 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1185353 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-103083 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
5507438 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-242427 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-48244 usd
jctcf Increase Decrease In Prepaid Income Taxes
IncreaseDecreaseInPrepaidIncomeTaxes
-208963 usd
jctcf Increase Decrease In Prepaid Income Taxes
IncreaseDecreaseInPrepaidIncomeTaxes
-249082 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1541107 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
692233 usd
us-gaap Increase Decrease In Accrued Taxes Payable
IncreaseDecreaseInAccruedTaxesPayable
147215 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1549773 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4042504 usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
102500 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
215685 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1011359 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-318185 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1011359 usd
us-gaap Proceeds From Repayments Of Debt
ProceedsFromRepaymentsOfDebt
1000000 usd
us-gaap Proceeds From Repayments Of Debt
ProceedsFromRepaymentsOfDebt
6000000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1000000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
6000000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
2231588 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
946137 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
484463 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1184313 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2716051 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2130450 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_846_eus-gaap--UseOfEstimates_z7VWf5qyGyHi" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><b><span id="xdx_86B_zk61iNHFuP9e">Estimates</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The preparation of consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates incorporated into the Company’s consolidated financial statements include the estimated useful lives for depreciable and amortizable assets, the estimated allowances for doubtful accounts receivable and inventory obsolescence, possible product liability and possible product returns, and litigation contingencies and claims. Actual results could differ from those estimates.</p>
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2716051 usd
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
484463 usd
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1494111 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-310847 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1372789 usd
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3498899 shares
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
734951 usd
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3492842 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3498000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3492266 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3498899 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3492842 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3498000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3492266 shares
CY2023Q2 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
2716051 usd
CY2023Q2 jctcf Wood Products And Metal Products
WoodProductsAndMetalProducts
19993945 usd
CY2022Q3 jctcf Wood Products And Metal Products
WoodProductsAndMetalProducts
20130063 usd
CY2023Q2 jctcf Agricultural Seed Products
AgriculturalSeedProducts
535285 usd
CY2022Q3 jctcf Agricultural Seed Products
AgriculturalSeedProducts
502250 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
20529230 usd
CY2022Q3 us-gaap Inventory Net
InventoryNet
20632313 usd
CY2023Q2 jctcf Office Equipment
OfficeEquipment
665483 usd
CY2022Q3 jctcf Office Equipment
OfficeEquipment
636501 usd
CY2023Q2 jctcf Warehouse Equipment
WarehouseEquipment
1576205 usd
CY2022Q3 jctcf Warehouse Equipment
WarehouseEquipment
1504867 usd
CY2023Q2 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
6209162 usd
CY2022Q3 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
6168080 usd
CY2023Q2 us-gaap Land
Land
559065 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
1856238 usd
CY2023Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Other Noncurrent Assets
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
36917514 usd
CY2022Q3 us-gaap Land
Land
559065 usd
CY2023Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
9009915 usd
CY2022Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
8868513 usd
CY2023Q2 jctcf Accumulated Depreciation Property Plant And Equipment
AccumulatedDepreciationPropertyPlantAndEquipment
4263928 usd
CY2022Q3 jctcf Accumulated Depreciation Property Plant And Equipment
AccumulatedDepreciationPropertyPlantAndEquipment
4040093 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4745987 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4828420 usd
CY2023Q2 us-gaap Intangible Assets Current
IntangibleAssetsCurrent
152540 usd
CY2022Q3 us-gaap Intangible Assets Current
IntangibleAssetsCurrent
50695 usd
CY2023Q2 us-gaap Accumulated Amortization Deferred Finance Costs
AccumulatedAmortizationDeferredFinanceCosts
18141 usd
CY2022Q3 us-gaap Accumulated Amortization Deferred Finance Costs
AccumulatedAmortizationDeferredFinanceCosts
17337 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
134399 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
33358 usd
CY2023Q2 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
391564 usd
CY2022Q3 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
24998 usd
CY2023Q2 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
12000000 usd
us-gaap Line Of Credit Facility Maximum Monthend Outstanding Amount
LineOfCreditFacilityMaximumMonthendOutstandingAmount
8000000 usd
CY2022 us-gaap Line Of Credit Facility Maximum Monthend Outstanding Amount
LineOfCreditFacilityMaximumMonthendOutstandingAmount
7000000 usd
CY2023Q2 us-gaap Line Of Credit
LineOfCredit
10000000 usd
CY2022Q3 us-gaap Line Of Credit
LineOfCredit
12000000 usd
CY2023Q2 us-gaap Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
0.0665 pure
us-gaap Pension Contributions
PensionContributions
404541 usd
us-gaap Pension Contributions
PensionContributions
426436 usd
us-gaap Revenues
Revenues
39666658 usd
us-gaap Revenues
Revenues
47900665 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-319851 usd
CY2022Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Other Noncurrent Assets
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
37254359 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
299577 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
237001 usd
us-gaap Capital Expenditure Discontinued Operations
CapitalExpenditureDiscontinuedOperations
318185 usd
us-gaap Capital Expenditure Discontinued Operations
CapitalExpenditureDiscontinuedOperations
1011359 usd
jctcf Sales
Sales
24245936 usd
jctcf Sales
Sales
25309216 usd
us-gaap Concentration Risk Customer
ConcentrationRiskCustomer
66%
us-gaap Concentration Risk Customer
ConcentrationRiskCustomer
54%
jctcf Concentration Volume Of Purchases
ConcentrationVolumeOfPurchases
17831976 usd
jctcf Concentration Volume Of Purchases
ConcentrationVolumeOfPurchases
21313695 usd
us-gaap Interest Paid Net
InterestPaidNet
325933 usd
us-gaap Interest Paid Net
InterestPaidNet
98868 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
227685 usd
us-gaap Litigation Settlement Expense
LitigationSettlementExpense
300000 usd
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
1000000 usd
CY2023Q2 us-gaap Line Of Credit Facility Current Borrowing Capacity
LineOfCreditFacilityCurrentBorrowingCapacity
7000000 usd

Files In Submission

Name View Source Status
jctcf-20230531_pre.xml Edgar Link unprocessable
0001079973-23-000950-index-headers.html Edgar Link pending
0001079973-23-000950-index.html Edgar Link pending
0001079973-23-000950.txt Edgar Link pending
0001079973-23-000950-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
jctcf-20230531.xsd Edgar Link pending
jctcf_ex31z1.htm Edgar Link pending
jctcf_ex31z2.htm Edgar Link pending
jctcf_ex32z1.htm Edgar Link pending
jctcf_ex32z2.htm Edgar Link pending
jctc_10q-053123.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
jctcf-20230531_cal.xml Edgar Link unprocessable
jctc_10q-053123_htm.xml Edgar Link completed
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
jctcf-20230531_def.xml Edgar Link unprocessable
jctcf-20230531_lab.xml Edgar Link unprocessable